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Background
The United States is comprised of an aging 
population; adults over the age of 85 are 
the fastest-growing age group in the United 
States and will reach approximately 9 
million in 2030.1  25% of patients ≥ 65 years 
old in the United States report falling each 
year.1 There are over 3 million emergency 
department visits related to falls in the 
United States, totaling approximately 50 
billion dollars in total medical 
expenditures.2
Falls are a major threat for older adults as 
they can lead to increased risk of further 
injury, loss of independence, decreased 
mobility, and premature death.1,2 Despite 
numerous studies showing evidence that 
multifactorial fall risk interventions are 
effective in decreasing fall risk, older adults 
who have an injurious fall often do not 
receive meaningful interventions to 
mitigate their fall risk. 3,4,5
Polypharmacy and high-risk medication 
(HRM) use is one such modifiable fall risk 
factor. In 2015, it was estimated that 29% 
of older adults in the United States had 
filled at least one medication listed in the 
Beers Criteria. Studies have demonstrated 
that primary care pharmacists can help 
bridge that gap and play an important role 
in the interdisciplinary healthcare team by 
identifying and intervening to reduce HRMs 
use in older adults.7
The Seniors At risk for Falls after Emergency 
Room visits (SAFER) project was created in 
2018 to better serve seniors greater than 
75 years of age who go to the Emergency 
Room for a fall, increase coordinated 
services, improve various outcome 
measures, and appreciate cost savings for 
delivery side and health plan with less 
costly services. SAFER provides a structured 
pathway to help teams provide tailored
care to at-risk seniors. 
Purpose
Falls continue to be a significant cause of 
morbidity and mortality in older adults, with 
falls accounting for 70% of accidental deaths 
in patients who are 75 years of age or older.1
This project is a sub-analysis of a larger 
multi-clinic study examining multifactorial 
fall-risk interventions in the primary care 
setting. The purpose of this project is to 
describe medication and pharmacy-related 
variables for both an intervention and 
matched control group of patients 75 years 
of age and older admitted to the Emergency 
Department (ED) for a fall and quantitively 
assess the outcome of interventions. 
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Results
Conclusion
The SAFER intervention helped increase pharmacist consults after patients 
who are greater than 75 years of age are admitted to the ED for falls. To 
understand the clinical impact of increased pharmacist consults, 




This project was a retrospective comparative cohort analysis of patients in the SAFER 
project in four Providence Medical Group (PMG) primary care clinics from December 
2018 to June 2019 in the Portland metro area. Inclusion criteria included patients 
who were active PMG patients at a SAFER pilot clinic, ≥75 years, prescribed ≥1 high-
risk medication associated with increased falls, and went to the ED for a fall. 
Exclusion criteria included no clinic visits in the previous two years, enrollment in 
hospice or hospitalization, skilled nursing facility discharge, and death within two 
weeks of ED visit. For purposes of analysis, patients were matched by age, gender, 
Stopping Elderly Accidents, Deaths, and Injuries (STEADI) fall risk score and 
geographic location: eastside, westside, and southern Oregon and stratified by the 
STEADI score. A comparator group of patients who met inclusion criteria but were 
not enrolled in the SAFER project were used as a matched control group. 
Descriptive statistics include: patient demographics across control and intervention 
groups; occurrence of pharmacy (PharmD) consults during and after the formal 
intervention period; whether patients were on Vitamin D3; and changes in HRMs. 
Control (n = 121) SAFER (n = 122)
Age 84.46 (5.59) 84.62 (5.57)
Female 68.59% 68.85%
White 90% 90%
Lives at Home 22.3% 18.85%
Lives at Home with Roommates or 
Other Family Member
27.27% 23.7%





































Vitamin D on Medication List Pre and Post ED 
Pre-ED Visit Post-ED Visit
Figure 1. This figure shows the baseline characteristics of both the control and intervention group
Figure 2. This figure compares the percentage of pharmacist consults completed post-ED admission for Falls between the SAFER 
and control group.  
* denotes statistical significance
Figure 3. This figure shows the percentage of the High Risk Medication drug class change from the control group to SAFER; Drugs to 
right of 0% increased more in SAFER group. 



























Difference in PharmD Consult Completed Post ED Visit vs. Pre ED Visit
*
Discussion
• Results reflect a retrospective comparative cohort analysis.
• Baseline characteristics of both groups were comparable.
• There were significantly more PharmD consults completed post-ED visit 
compared to pre-ED visit between SAFER and control group (0.479 vs 
0.016; P <0.0001).
• 16 different HRM classes for pre-ED and post-ED visits in both groups 
were analyzed but did not show a statistical or clinical difference.
• Prescription of Vitamin D significantly increased in both the SAFER and 
Control group with p values of 0.0093 and 0.0124, respectively. The 
difference in Vitamin D prescriptions between SAFER and control was 
not statistically significant.
Limitations:
• This study does not exclude patients who have died during the study (44 
patients total).
• This study did not analyze which medications in each HRM drug class 
were continued or discontinued.
• This study did not analyze what was being recommended during the 
PharmD consults and whether recommendations were followed.
• This study did not include combination products that include opioids 
such as hydrocodone-acetaminophen or oxycodone-acetaminophen
• This study did not look at tapering or dose decrease of HRMs.
































Difference in the number of High Risk Medications in SAFER vs Control 
